- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Treatment responses with once-weekly teriparatide therapy for osteoporosis ; volume:27 ; number:10 ; day:27 ; month:5 ; year:2016 ; pages:3057-3062 ; date:10.2016
Osteoporosis international ; 27, Heft 10 (27.5.2016), 3057-3062, 10.2016
- Urheber
-
Shiraki, M.
- Beteiligte Personen und Organisationen
-
Ueda, S.
Sugimoto, T.
Kuroda, T.
Nakamura, T.
SpringerLink (Online service)
- DOI
-
10.1007/s00198-016-3640-5
- URN
-
urn:nbn:de:1111-2016110534532
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Shiraki, M.
- Ueda, S.
- Sugimoto, T.
- Kuroda, T.
- Nakamura, T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
Long-term outcomes of once weekly v. twice weekly sessions of cognitive behavioral therapy and interpersonal psychotherapy for depression
Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial
Osteoporosis : diagnosis, prevention, therapy
Pharmacological therapy of osteoporosis
The once and future gene therapy
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
Long-term outcomes of once weekly v. twice weekly sessions of cognitive behavioral therapy and interpersonal psychotherapy for depression
Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial
Osteoporosis : diagnosis, prevention, therapy
Pharmacological therapy of osteoporosis
The once and future gene therapy
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk
Repositioning of Omarigliptin as a once-weekly intranasal Anti-parkinsonian Agent
Once-weekly teriparatide improves glucocorticoid-induced osteoporosis in patients with inadequate response to bisphosphonates
Study of twice-weekly injections of Teriparatide by comparing efficacy with once-weekly injections in osteoporosis patients: the TWICE study
Once-weekly teriparatide administration for 24 weeks in postmenopausal women with osteoporosis: reply to T. Kawada
Cost Effectiveness of Once-Weekly Semaglutide Versus Once-Weekly Dulaglutide in the Treatment of Type 2 Diabetes in Canada
Long-term outcomes of once weekly v. twice weekly sessions of cognitive behavioral therapy and interpersonal psychotherapy for depression
Comparison of different dosing regimens (once weekly vs. twice weekly, and once weekly vs. once every two weeks) with epoetin delta in patients with chronic kidney disease: a randomized controlled trial
Osteoporosis : diagnosis, prevention, therapy
Pharmacological therapy of osteoporosis
The once and future gene therapy
Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
24-Month Open-Label Teriparatide Once-Weekly Efficacy Research Trial Examining Bone Mineral Density in Subjects with Primary Osteoporosis and High Fracture Risk